Tourmaline Bio, Inc.
US ˙ NasdaqGS ˙ US89157D1054

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Francois Nader. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Francois Nader har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:TALS / Talaris Therapeutics Inc Director 386.932
US:MRNA / Moderna, Inc. Director 16.620
US:XLRN / Acceleron Pharma Inc Director 0
US:US00C4W1JQ50 / Alexion Pharmaceuticals, Inc. Director 0
Director 0
US:BXLT / Baxalta Incorporated Director 0
US:TRVN / Trevena, Inc. Director 8.870
US:NPSP / NPS Pharmaceuticals Inc President, CEO and Director, Director 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Francois Nader. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb TRML / Tourmaline Bio, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i TRML / Tourmaline Bio, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2022-07-21 TALS Nader Francois 36.500 3,7200 36.500 3,7200 135.780 14 5.0300 47.815 35,22
2022-07-20 TALS Nader Francois 52.000 3,6200 52.000 3,6200 188.240
2022-07-19 TALS Nader Francois 50.000 3,5200 50.000 3,5200 176.000
2022-07-19 TALS Nader Francois 50.000 3,5200 50.000 3,5200 176.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TRML / Tourmaline Bio, Inc. Insider Trades
Insidersalg TRML / Tourmaline Bio, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i TRML / Tourmaline Bio, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TRML / Tourmaline Bio, Inc. Insider Trades
Insiderkøb TRVN / Trevena, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i TRML / Tourmaline Bio, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TRVN / Trevena, Inc. Insider Trades
Insidersalg TRVN / Trevena, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i TRML / Tourmaline Bio, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TRVN / Trevena, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Francois Nader som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2022-09-13 2022-07-25 4/A TALS Talaris Therapeutics, Inc.
Common Stock
J - Other 138.500 386.932 55,75
2022-09-13 2022-07-25 4/A TALS Talaris Therapeutics, Inc.
Common Stock
J - Other -138.500 0 -100,00
2022-09-13 2022-07-21 4/A TALS Talaris Therapeutics, Inc.
Common Stock
P - Purchase 36.500 138.500 35,78 3,72 135.780 515.220
2022-09-13 2022-07-21 4/A TALS Talaris Therapeutics, Inc.
Common Stock
J - Other 248.432 248.432
2022-09-13 2022-07-21 4/A TALS Talaris Therapeutics, Inc.
Common Stock
J - Other -248.432 147.255 -62,78
2022-09-13 2022-07-20 4/A TALS Talaris Therapeutics, Inc.
Common Stock
P - Purchase 52.000 102.000 104,00 3,62 188.240 369.240
2022-09-13 2022-07-19 4/A TALS Talaris Therapeutics, Inc.
Common Stock
P - Purchase 50.000 50.000 3,52 176.000 176.000
2022-07-25 2022-07-25 4 TALS Talaris Therapeutics, Inc.
Common Stock
J - Other 138.500 386.932 55,75
2022-07-25 2022-07-25 4 TALS Talaris Therapeutics, Inc.
Common Stock
J - Other -138.500 0 -100,00
2022-07-25 2022-07-21 4 TALS Talaris Therapeutics, Inc.
Common Stock
P - Purchase 36.500 138.500 35,78 3,72 135.780 515.220
2022-07-25 2022-07-21 4 TALS Talaris Therapeutics, Inc.
Common Stock
J - Other 248.432 248.432
2022-07-25 2022-07-21 4 TALS Talaris Therapeutics, Inc.
Common Stock
J - Other -248.432 87.735 -73,90
2022-07-25 2022-07-20 4 TALS Talaris Therapeutics, Inc.
Common Stock
P - Purchase 52.000 102.000 104,00 3,62 188.240 369.240
2022-07-25 2022-07-19 4 TALS Talaris Therapeutics, Inc.
Common Stock
P - Purchase 50.000 50.000 3,52 176.000 176.000
2022-05-12 2022-05-10 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
M - Exercise X -23.100 16.620 -58,16
2022-05-12 2022-05-10 4 MRNA Moderna, Inc.
Common Stock
S - Sale -3.196 20.607 -13,43 136,10 -434.976 2.804.613
2022-05-12 2022-05-10 4 MRNA Moderna, Inc.
Common Stock
M - Exercise X 23.100 23.803 3.285,92 18,87 435.897 449.163
2022-05-02 2022-04-28 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
A - Award 5.415 5.415
2022-05-02 2022-04-28 4 MRNA Moderna, Inc.
Restricted Stock Units
M - Exercise -703 0 -100,00
2022-05-02 2022-04-28 4 MRNA Moderna, Inc.
Common Stock
M - Exercise 703 703
2021-12-16 2021-12-15 4 TALS Talaris Therapeutics, Inc.
Common Stock
G - Gift -59.520 336.167 -15,04
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer -3.222 0 -100,00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer -8.185 0 -100,00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer -7.500 0 -100,00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer -20.000 0 -100,00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer -576 0 -100,00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer -7.500 0 -100,00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer -10.000 0 -100,00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer -10.000 0 -100,00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer -7.500 0 -100,00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Common Stock
U - Other -6.749 0 -100,00
2021-07-23 2021-07-21 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
D - Sale to Issuer -13.921 0 -100,00
2021-05-24 2021-05-20 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 673 13.921 5,08
2021-05-24 2021-05-20 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 1.962 13.248 17,38
2021-05-06 3 TALS Talaris Therapeutics, Inc.
Common Stock
395.687
2021-04-30 2021-04-28 4 MRNA Moderna, Inc.
Restricted Stock Units
A - Award 703 703
2021-04-30 2021-04-28 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
A - Award 4.081 4.081
2021-02-02 2021-01-29 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 3.222 3.222
2021-02-02 2021-01-29 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 1.622 6.749 31,64
2021-01-26 2021-01-22 4 PRVL Prevail Therapeutics Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -17.000 0 -100,00
2021-01-26 2021-01-22 4 PRVL Prevail Therapeutics Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -32.000 0 -100,00
2021-01-26 2021-01-22 4 PRVL Prevail Therapeutics Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -133.447 0 -100,00
2021-01-26 2021-01-22 4 PRVL Prevail Therapeutics Inc.
Common Stock
U - Other -23.747 0 -100,00
2020-06-19 2020-06-17 4 PRVL Prevail Therapeutics Inc.
Stock Option (Right to Buy)
A - Award 17.000 17.000
2020-05-18 2020-05-14 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 941 11.286 9,10
2020-05-18 2020-05-14 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 3.468 10.345 50,43
2020-04-30 2020-04-29 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
A - Award 18.270 18.270
2020-01-24 2020-01-22 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 8.185 8.185
2020-01-24 2020-01-22 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 1.377 5.127 36,72
2019-12-11 2019-12-10 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
A - Award 17.889 17.889 18,87 337.565 337.565
2019-12-11 2019-12-10 4 MRNA Moderna, Inc.
Stock Option (Right to Buy)
A - Award 39.720 39.720 18,87 749.516 749.516
2019-06-25 2019-06-24 4 PRVL Prevail Therapeutics Inc.
Series B Preferred Stock
C - Conversion -23.747 0 -100,00
2019-06-25 2019-06-24 4 PRVL Prevail Therapeutics Inc.
Common Stock
C - Conversion 23.747 23.747
2019-05-17 2019-05-15 4 ALXN ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
A - Award 2.726 6.877 65,67
2019-01-29 2019-01-25 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 7.500 7.500
2019-01-29 2019-01-25 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 1.250 3.750 50,00
2018-05-11 2018-05-09 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 2.174 4.151 109,96
2018-03-05 2018-03-01 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 7.500 7.500
2018-03-05 2018-03-01 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 1.250 2.500 100,00
2017-11-30 2017-11-29 4 ALXN ALEXION PHARMACEUTICALS INC
Common Stock, par value $.0001 per share
A - Award 1.977 1.977
2017-03-14 2017-03-02 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 7.500 7.500
2017-03-14 2017-03-02 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 1.250 1.250
2016-06-07 2016-06-03 4 BXLT Baxalta Inc
Stock Option (Right to Buy)
D - Sale to Issuer -5.960 0 -100,00
2016-06-07 2016-06-03 4 BXLT Baxalta Inc
Common Stock, $0.01 par value
D - Sale to Issuer -7.657 0 -100,00
2016-05-12 2016-05-10 4 BXLT Baxalta Inc
Common Stock, $0.01 par value
A - Award 4.500 7.657 142,54
2016-03-07 2016-03-03 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 10.000 10.000
2015-07-29 2015-07-27 4 BXLT Baxalta Inc
Stock Option (Right to Buy)
A - Award 5.960 5.960
2015-07-29 2015-07-27 4 BXLT Baxalta Inc
Common Stock, par value $0.01 per share
A - Award -3.140 3.140 -50,00
2015-05-21 2015-05-20 4 TRVN TREVENA INC
Stock Option (Right to Buy)
A - Award 8.870 8.870
2015-04-08 2015-04-06 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 10.000 10.000
2015-04-08 2015-01-08 4/A XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 576 576
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Performance Units
D - Sale to Issuer -115.432 0 -100,00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Performance Units
D - Sale to Issuer -27.926 0 -100,00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
D - Sale to Issuer -24.302 0 -100,00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
D - Sale to Issuer -19.598 0 -100,00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
D - Sale to Issuer -80.912 0 -100,00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -109.602 0 -100,00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -82.826 0 -100,00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -67.636 0 -100,00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -154.284 0 -100,00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -133.125 0 -100,00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -104.438 0 -100,00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -196.018 0 -100,00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -106.643 0 -100,00
2015-02-24 2015-02-21 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
U - Other -276.955 0 -100,00 46,00 -12.739.930
2015-02-20 2015-02-13 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -24.301 24.302 -50,00
2015-02-20 2015-02-13 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
F - Taxes -12.600 276.955 -4,35 45,88 -578.088 12.706.695
2015-02-20 2015-02-13 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 24.301 289.555 9,16
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -9.798 19.598 -33,33
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 80.912 80.912
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Employee Stock Options (right to buy)
M - Exercise -653 106.643 -0,61
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Employee Stock Options (right to buy)
M - Exercise -3.262 104.438 -3,03
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Employee Stock Options (right to buy)
M - Exercise -24.466 191.534 -11,33
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Employee Stock Options (right to buy)
M - Exercise -5.625 67.636 -7,68
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
F - Taxes -4.943 265.254 -1,83 45,85 -226.637 12.161.896
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 9.798 270.197 3,76
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 653 260.399 0,25 38,27 24.990 9.965.470
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 3.262 259.746 1,27 8,21 26.781 2.132.515
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 24.466 256.484 10,54 3,34 81.716 856.657
2015-02-20 2015-02-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 5.625 232.018 2,48 3,25 18.281 754.058
2015-02-20 2015-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
F - Taxes -7.263 226.393 -3,11 45,85 -333.009 10.380.119
2015-02-20 2015-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
J - Other 20.301 233.656 9,52
2015-01-09 2015-01-08 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 576 576
2014-12-12 2014-12-11 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 20.000 20.000
2014-05-15 2014-05-14 4 TRVN TREVENA INC
Stock Option (Right to Buy)
A - Award 8.870 8.870
2014-04-18 2014-02-12 4 NPSP NPS PHARMACEUTICALS INC
Performance Units
A - Award 40.500 40.500
2014-02-14 2014-02-13 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -24.301 48.603 -33,33
2014-02-14 2014-02-13 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
F - Taxes -11.767 233.656 -4,79 38,30 -450.676 8.949.025
2014-02-14 2014-02-13 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 24.301 245.423 10,99
2014-02-14 2014-02-12 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 29.396 29.396
2014-02-14 2014-02-12 4 NPSP NPS PHARMACEUTICALS INC
Employee Stock Options (right to buy)
A - Award 107.296 107.296
2014-02-11 2014-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
F - Taxes -7.258 221.122 -3,18 35,13 -254.974 7.768.016
2014-02-11 2014-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
J - Other 20.300 228.380 9,76
2014-01-31 2014-01-30 4 TRVN TREVENA INC
Stock Option (Right to Buy)
A - Award 17.741 17.741
2014-01-30 3 TRVN TREVENA INC
Common Stock
0
2014-01-09 2014-01-07 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
A - Award 20.250 216.000 10,34
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -16.739 73.261 -18,60
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -10.398 109.602 -8,66
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -5.850 0 -100,00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -4.500 0 -100,00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -3.150 0 -100,00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -5.746 0 -100,00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -4.875 0 -100,00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -3.750 0 -100,00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -2.625 0 -100,00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -9.030 0 -100,00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -2.771 0 -100,00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -2.308 0 -100,00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -1.775 0 -100,00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -1.243 0 -100,00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise -64.356 0 -100,00
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 16.739 226.936 7,96 3,25 54.402 737.542
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 10.398 210.197 5,20 5,71 59.373 1.200.225
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 5.850 199.799 3,02 6,16 36.036 1.230.762
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 4.500 193.949 2,38 5,85 26.325 1.134.602
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 3.150 189.449 1,69 5,05 15.908 956.717
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 5.746 186.299 3,18 3,60 20.686 670.676
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 4.875 180.553 2,77 3,93 19.159 709.573
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 3.750 175.678 2,18 4,10 15.375 720.280
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 2.625 171.928 1,55 4,42 11.602 759.922
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 9.030 169.303 5,63 4,13 37.294 699.221
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 2.771 160.273 1,76 4,31 11.943 690.777
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 2.308 157.502 1,49 4,37 10.086 688.284
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 1.775 155.194 1,16 4,50 7.988 698.373
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 1.243 153.419 0,82 4,07 5.059 624.415
2013-12-16 2013-12-12 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 64.356 152.176 73,28 5,73 368.760 871.968
2013-09-30 2013-09-27 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
M - Exercise X -9.800 82.826 -10,58
2013-09-30 2013-09-27 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
M - Exercise X -16.650 5.850 -74,00
2013-09-30 2013-09-27 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
M - Exercise X -17.008 4.500 -79,08
2013-09-30 2013-09-27 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -43.458 87.820 -33,10 32,36 -1.406.118 2.841.486
2013-09-30 2013-09-27 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 9.800 131.278 8,07 5,71 55.958 749.597
2013-09-30 2013-09-27 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 16.650 121.478 15,88 6,16 102.564 748.304
2013-09-30 2013-09-27 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 17.008 104.828 19,37 5,85 99.497 613.244
2013-09-30 2013-09-26 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
M - Exercise X -992 21.508 -4,41
2013-09-30 2013-09-26 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
M - Exercise X -19.350 3.150 -86,00
2013-09-30 2013-09-26 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -6.497 87.820 -6,89 33,60 -218.299 2.950.752
2013-09-30 2013-09-26 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -143.503 94.317 -60,34 33,07 -4.745.644 3.119.063
2013-09-30 2013-09-26 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 992 237.820 0,42 5,85 5.803 1.391.247
2013-09-30 2013-09-26 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 19.350 236.828 8,90 5,05 97.718 1.195.981
2013-04-10 2013-04-10 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -54.000 54.000 -50,00
2013-04-10 2013-04-10 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -16.754 5.746 -74,46
2013-04-10 2013-04-10 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -58.231 0 -100,00
2013-04-10 2013-04-10 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -148.367 217.478 -40,55 11,68 -1.732.526 2.539.556
2013-04-10 2013-04-10 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 54.000 365.845 17,32 3,34 180.360 1.221.922
2013-04-10 2013-04-10 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 16.754 311.845 5,68 3,60 60.314 1.122.642
2013-04-10 2013-04-10 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 58.231 295.091 24,58 3,85 224.189 1.136.100
2013-04-10 2013-04-09 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -41.769 58.231 -41,77
2013-04-10 2013-04-09 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -13.875 4.875 -74,00
2013-04-10 2013-04-09 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -15.000 3.750 -80,00
2013-04-10 2013-04-09 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -79.356 0 -100,00
2013-04-10 2013-04-09 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -150.000 236.860 -38,77 11,27 -1.689.840 2.668.370
2013-04-10 2013-04-09 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 41.769 386.860 12,10 3,85 160.811 1.489.411
2013-04-10 2013-04-09 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 13.875 345.091 4,19 3,93 54.529 1.356.208
2013-04-10 2013-04-09 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 15.000 331.216 4,74 4,10 61.500 1.357.986
2013-04-10 2013-04-09 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 79.356 316.216 33,50 4,29 340.437 1.356.567
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -15.358 79.356 -16,22
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -16.125 2.625 -86,00
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -55.470 9.030 -86,00
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -6.104 2.771 -68,78
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -6.567 2.308 -73,99
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -7.100 1.775 -80,00
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -7.632 1.243 -85,99
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
M - Exercise X -35.644 64.356 -35,64
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
S - Sale X -150.000 236.860 -38,77 11,01 -1.650.795 2.606.715
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 15.358 386.860 4,13 4,29 65.886 1.659.629
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 16.125 371.502 4,54 4,42 71.272 1.642.039
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 55.470 355.377 18,50 4,13 229.091 1.467.707
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 6.104 299.907 2,08 4,31 26.308 1.292.599
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 6.567 293.803 2,29 4,37 28.698 1.283.919
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 7.100 287.236 2,53 4,50 31.950 1.292.562
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 7.632 280.136 2,80 4,07 31.062 1.140.154
2013-04-10 2013-04-08 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise X 35.644 272.504 15,05 5,73 204.240 1.561.448
2013-02-21 2013-02-19 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -50.000 50.000 -50,00
2013-02-21 2013-02-19 4 NPSP NPS PHARMACEUTICALS INC
Common stock
F - Taxes -21.624 236.126 -8,39 8,01 -173.208 1.891.369
2013-02-21 2013-02-19 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
M - Exercise 50.000 257.750 24,07
2013-02-15 2013-02-13 4 NPSP NPS PHARMACEUTICALS INC
Restricted Stock Units
A - Award 72.904 72.904
2013-02-15 2013-02-13 4 NPSP NPS PHARMACEUTICALS INC
Employee Stock Options (right to buy)
A - Award 196.018 196.018
2013-02-11 2013-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common stock
F - Taxes -7.193 207.750 -3,35 8,61 -61.932 1.788.728
2013-02-11 2013-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
J - Other 20.299 214.943 10,43
2012-12-26 2012-12-21 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
F - Taxes -11.068 154.043 -6,70 9,10 -100.719 1.401.791
2012-12-21 2012-12-21 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
A - Award 108.000 108.000
2012-02-09 2012-02-07 4 NPSP NPS PHARMACEUTICALS INC
Stock Option
A - Award 107.700 107.700
2012-02-09 2012-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
A - Award 60.900 60.900
2012-02-09 2012-02-07 4 NPSP NPS PHARMACEUTICALS INC
Common Stock
A - Award 60.900 60.900
2012-02-01 2012-01-20 4 NPSP NPS PHARMACEUTICALS INC
Options (right to buy)
A - Award 46.313 46.313
2012-02-01 2012-01-30 4 NPSP NPS PHARMACEUTICALS INC
Stock Options
A - Award 54.000 54.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)